South Dakota Investment Council lowered its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 3.8% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 32,007 shares of the pharmacy operator’s stock after selling 1,264 shares during the quarter. South Dakota Investment Council’s holdings in Walgreens Boots Alliance were worth $1,464,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Nations Financial Group Inc. IA ADV increased its holdings in Walgreens Boots Alliance by 2.9% in the fourth quarter. Nations Financial Group Inc. IA ADV now owns 7,031 shares of the pharmacy operator’s stock valued at $415,000 after purchasing an additional 196 shares during the last quarter. Dai Ichi Life Insurance Company Ltd grew its stake in Walgreens Boots Alliance by 0.3% in the fourth quarter. Dai Ichi Life Insurance Company Ltd now owns 65,529 shares of the pharmacy operator’s stock valued at $3,864,000 after acquiring an additional 196 shares during the period. Fiera Capital Corp grew its stake in Walgreens Boots Alliance by 4.0% in the fourth quarter. Fiera Capital Corp now owns 5,461 shares of the pharmacy operator’s stock valued at $322,000 after acquiring an additional 212 shares during the period. Motco boosted its position in shares of Walgreens Boots Alliance by 13.6% during the fourth quarter. Motco now owns 1,794 shares of the pharmacy operator’s stock worth $106,000 after buying an additional 215 shares during the period. Finally, Asset Dedication LLC boosted its position in shares of Walgreens Boots Alliance by 3.5% during the first quarter. Asset Dedication LLC now owns 7,199 shares of the pharmacy operator’s stock worth $337,000 after buying an additional 246 shares during the period. Institutional investors and hedge funds own 57.19% of the company’s stock.
Shares of NASDAQ WBA traded up $1.74 during mid-day trading on Tuesday, hitting $41.34. 155,331 shares of the stock traded hands, compared to its average volume of 7,348,387. The company has a debt-to-equity ratio of 1.34, a current ratio of 0.66 and a quick ratio of 0.32. Walgreens Boots Alliance Inc has a twelve month low of $36.65 and a twelve month high of $64.50. The company has a market cap of $34.74 billion, a PE ratio of 10.57, a price-to-earnings-growth ratio of 1.83 and a beta of 0.55. The firm has a 50 day simple moving average of $42.12 and a two-hundred day simple moving average of $51.06.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, April 2nd. The pharmacy operator reported $1.52 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.46 by $0.06. Walgreens Boots Alliance had a return on equity of 21.26% and a net margin of 2.52%. The company had revenue of $35.82 billion for the quarter, compared to the consensus estimate of $35.24 billion. During the same quarter last year, the business posted $1.64 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 3.7% on a year-over-year basis. On average, equities research analysts anticipate that Walgreens Boots Alliance Inc will post 5.53 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Wednesday, May 20th will be issued a dividend of $0.4575 per share. This represents a $1.83 annualized dividend and a dividend yield of 4.43%. The ex-dividend date of this dividend is Tuesday, May 19th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 30.55%.
Several research firms recently issued reports on WBA. Credit Suisse Group dropped their target price on Walgreens Boots Alliance from $60.00 to $50.00 and set a “neutral” rating on the stock in a report on Friday, April 3rd. ValuEngine lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, March 3rd. Deutsche Bank raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating and reduced their price target for the stock from $51.00 to $43.00 in a research report on Friday, April 3rd. Royal Bank of Canada reduced their price target on Walgreens Boots Alliance from $57.00 to $48.00 and set a “sector perform” rating on the stock in a research report on Friday, April 3rd. Finally, JPMorgan Chase & Co. reduced their price target on Walgreens Boots Alliance from $62.00 to $56.00 and set a “neutral” rating on the stock in a research report on Friday, April 3rd. Four investment analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $51.21.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Story: Calculating net profit and net profit margin ratio
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.